Other Events . On April 21, 2026, the board of directors of Aclarion, Inc. (the “Company”) authorized and approved a share repurchase program. Under the share repurchase program, the Company may repurchase up to $2.5 million in value of the Company’s outstanding shares of common stock from time to time over the next 12 months. The Company may buy back its common stock from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, pu…

Entry into a Material Definitive Agreement. The information set forth in

Material Modification to Rights of Security Holders. On March 19, 2026, the board of directors (the “ Board ”) of Aclarion, Inc., a Delaware corporation (the “ Company ”), adopted a stockholder rights agreement and declared (i) a dividend of one right (a “ Right ”) for each outstanding share of Company common stock, par value $0.00001 per share (“ Common Stock ”), to stockholders of record at the close of business on March 30, 2026 (the “ Record Date ”) and (ii) a dividend of the aggregate nu…

Entry into a Material Definitive Agreement. On January 8, 2026, Aclarion, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with the purchasers named therein. Pursuant to the terms of the Purchase Agreement, the Company agreed to sell, in a registered direct offering (the “ Offering ”), an aggregate of (i) 200,000 shares (the “ Shares ”) of its common stock, par value $0.00001 per share (“ Common Stock ”), at a price per share of $5.18 (or pre-fu…

Entry into a Material Definitive Agreement. On October 13, 2025, Aclarion, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with the purchasers named therein. Pursuant to the terms of the Purchase Agreement, the Company agreed to sell, in a registered direct offering (the “ Offering ”), an aggregate of (i) 64,000 shares (the “ Shares ”) of its common stock, par value $0.00001 per share (“ Common Stock ”), at a price per share of $8.36; and (ii)…

CFO — John Lorbiecki: John Lorbiecki is retiring from his position as CFO, and Gregory A. Gould has been appointed as the new CFO.

Entry into a Material Definitive Agreement. On September 2, 2025, the Company entered into an employment agreement (the “Employment Agreement”), with Gregory A. Gould, the Company’s newly appointed Chief Financial Officer. The Employment Agreement is effective as of September 1, 2025. The terms of the Employment Agreement are summarized below.

CFO — John Lorbiecki: Mr. Lorbiecki is retiring from his position as CFO, and the company has initiated a search for his replacement.

Material Modifications to Rights of Security Holders . To the extent required by

Entry into a Material Definitive Agreement. On January 30, 2025, Aclarion, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with the purchasers named therein. Pursuant to the terms of the Purchase Agreement, the Company agreed to sell, in a registered direct offering (the “ Offering ”), an aggregate of 506,803 shares (the “ Shares ”) of its common stock, par value $0.00001 per share, at a price per share of $9.25. The aggregate gross proceeds to…

Material Modifications to Rights of Security Holders . To the extent required by

Entry into a Material Definitive Agreement. Underwriting Agreement On January 15, 2025, Aclarion, Inc., a Delaware corporation (the “Company”) entered into an underwriting agreement “the “Underwriting Agreement’) with Dawson James Securities, Inc., as representative of the underwriter (the “Underwriter”) for the offer and sale (the “Offering”) of an aggregate of (i) 100,000 shares (the “Shares”) of its common stock, par value $0.00001 per share (“Common Stock”), (ii) 143,900,000 pre-funded wa…

Entry into a Material Definitive Agreement. On January 3, 2025, Aclarion, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with the purchasers named therein. Pursuant to the terms of the Purchase Agreement, the Company agreed to sell, in a registered direct offering (the “ Offering ”), an aggregate of 3,380,276 shares (the “ Shares ”) of its common stock, par value $0.00001 per share, at a price per share of $0.142. The aggregate gross proceeds…

Termination of a Material Definitive Agreement. On January 3, 2025, Aclarion, Inc. (the “ Company ”) gave notice to terminate the At-The-Market Issuance Sales Agreement that the Company entered into with Ascendiant Capital Markets, LLC on September 24, 2024 (the “ Sales Agreement ”), effective immediately. Under the Sales Agreement, the Company was permitted to sell, from time to time, shares of its common stock, par value $0.00001 per share (the “ Common Stock ”), having an aggregate offerin…

Unregistered Sales of Equity Securities The information contained in

Entry into a Material Definitive Agreement. Background As previously disclosed, on October 9, 2023, Aclarion, Inc. (the “Company”) entered into an equity line (“Equity Line”) common stock purchase agreement (the “Equity Line Purchase Agreement”) and a related registration rights agreement (the “RRA”) with White Lion Capital, LLC, a Nevada limited liability company (“White Lion”). Pursuant to the Equity Line Purchase Agreement, the Company has the right, but not the obligation to require White…

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Background April 2024 Previous Notice of $1 Bid Price Listing Issue As previously disclosed, on April 8, 2024, Aclarion, Inc. (the “Company”) received a written notice (the “April Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule…

Unregistered Sales of Equity Securities. The information set forth in

Entry into a Material Definitive Agreement. $1.0 Million Convertible Preferred Stock and Warrants Financing On September 30, 2024, Aclarion, Inc. (the “Company”, “we” and “us”) entered into a securities purchase agreement with accredited investors for a convertible preferred stock and warrants financing. The Company has received $1,000,000 of gross proceeds in connection with the closing of this financing. At the closing, the Company issued 1,000 shares of Series C convertible preferred stock…

Entry into a Material Definitive Agreement. On September 24, 2024, Aclarion, Inc. (the “ Company ”) entered into an At-the-Market Issuance Sales Agreement (the “ Sales Agreement ”) with Ascendiant Capital Markets, LLC, as sales agent (the “ Agent ”), to sell shares of its common stock, par value $0.00001 per share (the “ Common Stock ”), having an aggregate offering price of up to $10 million (the “ Shares ”) from time to time, through an “at the market offering” (the “ ATM Offering ”) as def…

Unregistered Sales of Equity Securities. The information set forth in

Entry into a Material Definitive Agreement. Issuance of Common Stock Pursuant to Offering Statement On August 27, 2024, Aclarion, Inc. (the “Company”), entered into a subscription agreement (the “Subscription Agreement”) with certain accredited investors, pursuant to which the Company agreed to issue and sell to the investors 1,000,000 shares (the “Shares”) of common stock of the Company, par value $0.00001 per share (the “Common Stock”), at a price of $0.29 per share for gross proceeds to th…

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Nasdaq Notice Regarding Stockholders’ Equity Requirement On August 22, 2024, Aclarion, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Stock Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing. In its a…

Entry into a Material Definitive Agreement. Background As previously disclosed, on September 1, 2023, Aclarion, Inc. (the “Company”, “we” and “us”) closed a financing for $862,500 of unsecured non-convertible notes due September 1, 2024. Exchange Agreement On August 14, 2024, the Company entered into an exchange agreement (the “Exchange Agreement”) with the note holders accredited investors to exchange approximately $930,000 of principal and accrued interest on the notes for 930 shares of new…

Unregistered Sales of Equity Securities. The information set forth in